[Parameters of PSA fractions in early diagnosis of prostatic cancer in healthy males over 50].

Urologiia i nefrologiia Pub Date : 1999-01-01
O B Loran, L V Krokhotina, D Iu Pushkar', A Z Valiev, P I Rasner
{"title":"[Parameters of PSA fractions in early diagnosis of prostatic cancer in healthy males over 50].","authors":"O B Loran,&nbsp;L V Krokhotina,&nbsp;D Iu Pushkar',&nbsp;A Z Valiev,&nbsp;P I Rasner","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>292 symptomless males aged 50-85 years were examined for blood prostate-specific antigen (PSA) for early diagnosis of prostatic cancer. Males with total PSA (TPSA) higher than age-specific standard underwent free PSA (FPSA) assay to estimate FPSA/TPSA and transperineal biopsy of the prostate. TPSA ranged from 0.3 to 112.0 ng/ml and exceeded the age standard in 102 examinees (35%). Prognostically unfavorable FPSA/TPSA (under 15%) was registered in 17(5.8%) examinees. Biopsy of the prostate has revealed cancer in 7 of them. Among those whose TPSA was above the standard, but FPSA/TPSA > 15%, morphologically verified prostatic cancer was detected in 5 males. It is thought valid to include the method of PSA fractions estimation in the program of screening for males at risk to develop prostatic cancer as it is simple, cost effective and highly informative.</p>","PeriodicalId":23468,"journal":{"name":"Urologiia i nefrologiia","volume":" 1","pages":"19-21"},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologiia i nefrologiia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

292 symptomless males aged 50-85 years were examined for blood prostate-specific antigen (PSA) for early diagnosis of prostatic cancer. Males with total PSA (TPSA) higher than age-specific standard underwent free PSA (FPSA) assay to estimate FPSA/TPSA and transperineal biopsy of the prostate. TPSA ranged from 0.3 to 112.0 ng/ml and exceeded the age standard in 102 examinees (35%). Prognostically unfavorable FPSA/TPSA (under 15%) was registered in 17(5.8%) examinees. Biopsy of the prostate has revealed cancer in 7 of them. Among those whose TPSA was above the standard, but FPSA/TPSA > 15%, morphologically verified prostatic cancer was detected in 5 males. It is thought valid to include the method of PSA fractions estimation in the program of screening for males at risk to develop prostatic cancer as it is simple, cost effective and highly informative.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[50岁以上健康男性前列腺癌早期诊断的PSA分数参数]。
本文对292例50 ~ 85岁无症状男性进行前列腺特异性抗原(PSA)检测,以期早期诊断前列腺癌。总PSA (TPSA)高于年龄特异性标准的男性进行游离PSA (FPSA)测定以估计FPSA/TPSA和前列腺经会阴活检。TPSA范围在0.3 ~ 112.0 ng/ml之间,102例(35%)超过年龄标准。17名(5.8%)考生预后不良的FPSA/TPSA(低于15%)。前列腺活检显示其中7人患有癌症。在TPSA高于标准,但FPSA/TPSA > 15%的男性中,形态学证实有5人检出前列腺癌。认为将PSA分值估算方法纳入前列腺癌高危男性筛查方案是有效的,因为它简单、经济、信息丰富。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Effect of low-intensity laser therapy on urinary tract function]. [Statistics of oncourologic diseases in Russia in 1996]. [Experience in using laser surgery of the prostate gland in patients with a functioning pacemaker]. [Some indicators of immunity in patients with urinary stones before and after extracorporeal lithotripsy]. [Citrate therapy in treating urate nephrolithiasis].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1